Tumor volume measurements were obtained by ultrasound (US) once a week, and treatment was administered intraperitoneally as documented in Figure 1A. Compared with the isotype control, a-PD-1 significantly reduced tumor growth while AVID200 had no significant impact on tumor growth in the KPC-4545 model. Here, PDCD1 is linked to neoplasm.